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Much hypoxia research has been carried out at high altitude in a hypobaric hypoxia (HH) environment. Many
research teams seek to replicate high-altitude conditions at lower altitudes in either hypobaric hypoxic conditions
or normobaric hypoxic (NH) laboratories. Implicit in this approach is the assumption that the only relevant condition
that differs between these settings is the partial pressure of oxygen (PO2), which is commonly presumed to be the
principal physiological stimulus to adaptation at high altitude. This systematic review is the first to present an overview
of the current available literature regarding crossover studies relating to the different effects of HH and NH on human
physiology. After applying our inclusion and exclusion criteria, 13 studies were deemed eligible for inclusion. Several
studies reported a number of variables (e.g. minute ventilation and NO levels) that were different between the two
conditions, lending support to the notion that true physiological difference is indeed present. However, the presence
of confounding factors such as time spent in hypoxia, temperature, and humidity, and the limited statistical power due
to small sample sizes, limit the conclusions that can be drawn from these findings. Standardisation of the study
methods and reporting may aid interpretation of future studies and thereby improve the quality of data in this area.
This is important to improve the quality of data that is used for improving the understanding of hypoxia
tolerance, both at altitude and in the clinical setting.
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Hypoxia research has numerous applications. These in-
clude investigating the pathogenesis and developing treat-
ments for medical conditions characterised by hypoxia [1]
and acute high altitude illness [2], as well as setting
optimum training regimes for athletes [3].
Much hypoxia research has been carried out at high
altitude in a hypobaric hypoxia (HH) environment. Such
‘field’ studies present practical and logistical challenges
including safety concerns about carrying out invasive
procedures in a remote setting. For these reasons, many
research teams seek to replicate high-altitude conditions
at lower altitudes in either hypobaric hypoxic conditions
or normobaric hypoxic (NH) laboratories. In these two* Correspondence: jonny.coppel@gmail.com
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unless otherwise stated.conditions, the hypoxic dose is calculated by the com-
bination of the various barometric pressures × inspired
fraction of oxygen [4]. As emphasised in Conkin's ‘Cri-
tique of the equivalent air altitude model’ [5], implicit in
this approach is the assumption that the only relevant
condition that differs between these settings is the par-
tial pressure of oxygen (PO2), which is commonly pre-
sumed to be the principal physiological stimulus to
adaptation at high altitude [6]. Although this assumption
underpins the interpretation of many studies that form
the basis of hypoxia physiology, it remains open to ques-
tion as recently highlighted by Millet et al. [7] and con-
troversy exists relating to the sporadic data in this area
with various opinions on the matter as discussed in a re-
cent series of ‘point-counterpoints’ [8]. The notion that
HH and NH environments are interchangeable in terms
of their effect on physiological responses is not proven.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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fields. Many national teams in various sports incorporate
altitude or hypoxic training into their programmes to aid
haematological adaptations [3]. Additionally, armies across
the world employ pre-acclimatisation strategies to train
troops for deployment at high altitude [9]. This issue also
applies to medical research such as therapeutic intermit-
tent hypoxic methods [10] or critical care research into
tissue hypoxia [1]. Thus, understanding the different im-
pacts of NH and HH on physiology is important.
The aim of this systematic review is to conduct a com-
prehensive systematic literature search to address the
questions: do humans react differently to HH when
compared with NH (when evaluated in studies with a
crossover design)?
Review: methods
Criteria for considering studies for this review
Candidate studies were identified using the following cri-
teria (Figure 1).
Types of studies
We searched for primary research articles describing
crossover trials comparing physiological responses to
NH and HH. Only crossover trials were considered due
to the large inter-subject variation in their response to
hypoxia.
Types of participants
We included studies involving lowland (defined as per-
manently living in locations <2,000 m) human subjects
of any age who were not acclimatised to high altitude.
Types of interventions
We compared NH and HH. NH and HH must be calcu-
lated to be equivalent to the same altitude. We included
studies investigating any duration of exposure, and theFigure 1 Methodology flow chart. This flow chart shows search methodHH may have been performed either at sea level in a
hypobaric chamber or at high altitude.
Types of outcome measures
Outcome variables were any human physiological re-
sponse to atmospheric hypoxia. These responses included
common phenotypes of interest in high altitude literature
including (but not limited to) ventilation, hypoxaemia, ex-
ercise metabolism, nitric oxide (NO) production, osmotic
balance, erythropoiesis and high-altitude illness.
Search methods for identification of studies
Search strategy
We attempted to identify all relevant trials regardless of
language or publication status (published, unpublished,
in press, and in progress). A literature search was car-
ried out using the search engines Embase (all to date),
Medline (performed on 15 October 2013) and Web of
Science (performed on 15 October 2013). Snowballing
was carried out; thus, the reference lists of all the short-
listed studies were checked for possible eligible studies.
Search terms
Search terms include (‘Hypobari* hypoxia’ OR ‘simulated
altitude’ OR ‘hypobari* anoxia’) AND (‘normbari* hyp-
oxia’ OR ‘sea level hypoxia’ OR ‘sea-level hypoxia’ OR
‘normobari* anoxia’).
Data collection and analysis
Selection of studies
Titles and abstracts of candidate studies were screened
for eligibility and duplicate references independently by
two authors (JC and EG). The reasons for study exclu-
sion were independently documented. For those papers
that could not be excluded based on their titles and ab-
stracts, the full paper was read to confirm eligibility.
We resolved disagreements by consulting a third authorology and results.
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sistance of translators when abstracts were not available
in English.
Data extraction and management
Using data extraction forms, JC extracted information
from each study and EG crosschecked the data. Data
fields within the data extraction forms were directly
linked to the formulated review question and planned
assessment of included studies.
The data extraction forms contained the following infor-
mation: study reference and reviewer identity, verification
of study eligibility, study characteristics, study quality (see
Quality of data section below), research methods, partici-
pants, intervention, outcome measures, results, and
additional information.
Assessment of risk of bias and study quality in included
studies
The risk of bias was independently assessed by JC and EG.
Studies that do not report statistical significance (P values)
for reported results were included, but their results were
considered either as high risk of bias or unclear. In terms
of study quality, we assessed the following: randomisation
of subjects for the order of the crossover and whether they
were blinded, length of washout period, presence/absence
of sample size calculations, whether the statistical analyses
accounted for the increased risk of type I errors when ana-
lysing large numbers of variables (adjustment for multiple
comparisons), test-retest reliability, normalisation of test-
ing environments for humidity (pH2O) as this can impact
hypoxic dose calculations [11], and control of carbon
dioxide (CO2) in the testing environments.
Data synthesis
The results were tabulated and compared. No statistical
analysis was carried out because the heterogeneity of the
studies was such that the data could not be pooled (see
below). Studies were categorised according to duration
of hypoxic exposure. One hour was used as the cut off
between ‘long’ and ‘short’ studies. All variables identified
through our search strategy are highlighted in Table 1
(List of variables) but due to the number of variables re-
ported, not all are considered in the written results and
discussion. Emphasis is placed on the major physio-
logical variables and those that are reported in more
than one study. This was because a consistent result
across multiple independent studies suggests validity of
the finding. Additionally, when study characteristics
were being determined, if a study did not mention a de-
sign feature, such as randomization of exposure order, it
was assumed that the feature was not present. The re-
sults for each variable and time point can be found in
Tables 2, 3, 4, 5, 6.Review: results
Studies
A total of 225 unique articles were identified in the
EMBASE, MEDLINE and Web of Science searches.
After applying our inclusion and exclusion criteria, 13
studies were deemed eligible for inclusion (Table 2:
Study design). A total of 153 subjects were included in
our review. Of these, six subjects were women and nine
had chronic airflow limitations. One study was added
after snowballing [12].
The studies investigated simulated altitudes from
1,700 m to 7,620 m, and exposure to the hypoxia lasted
between 5 min to 24 h. The 13 studies were carried out
in seven different countries: Australia (1), Japan (1),
Spain (1), Sweden (1), Switzerland (2), France (2), and
America (5).
Variables measured
Quality of data
Study design Nine studies [12-20] randomised the order
of the crossover. Three studies [6,21,22] did not, and one
[23] was ambiguous as to whether randomization was
used or not. Three studies [12,18,22] had a washout
period of at least 14 days, six studies [13-17,21] used 7
days, and four studies [6,19,20,23] used less than 24 h.
The largest study involved 20 people, the smallest 7,
and the mean was 12. None of the studies stated they
had conducted a sample size calculation to justify their
chosen number. Only two studies [12,23] mentioned ac-
counting for the inflated risk of type I errors that arises
when multiple comparisons are made, and both of these
performed Bonferroni adjustments. Only one study mea-
sured the test-retest reliability of their outcome variable
[23]. They performed an intra-class coefficient correl-
ation and showed a good reliability of the postural stabil-
ity measurements.
The methods used to control the degree of hypoxia
administered in each study varied. Five studies men-
tioned controlling the relative humidity between HH
and NH. Of these, three [15,17,18] maintained 50% hu-
midity (±1%) and two [13,14] maintained it between 45%
and 55%. One paper [6] specifically mentioned the meas-
urement and control of CO2 levels in the chambers
using CO2 scrubbers.
Ventilation
Eight studies were identified that reported ventilation
and oxygenation. Five of these lasted ≥1 h (long studies)
[12,13,15,22,16], and three lasted <1 h (short studies)
[17,18,21]. Five out of seven studies reporting minute
ventilation reported values that were significantly lower
in HH [12,13,17,21,22] (by up to 4 L/min) [13] (Figure 2:
Graph of minute ventilation), whereas two identified no
difference between conditions [15,18]. Consistent with
Table 1 List of variables
Oxygenation and ventilation Cardiovascular AMS (acute mountain sickness)
and neurology
Other
Ventilation (VE) Hypoxic cardiac response (HCR) Postural stability Sweat rates
Tidal volume (VT) Forced vascular conductance
Lake Louise AMS scores Oesophageal temperature thresholds
for increasing forearm skin vascular
conductance
Respiratory rate (Bf) Heart rate variability (LH/HF)
Exhaled nitric oxide (NO) levels
(exNO)
Oesophageal temperature thresholds
for increased sweat rate
Heart rate (HR)
Oesophageal temperature
End tidal partial pressure of oxygen
(PetO2)
Stroke volume (SV) Skin temperature
Urine volume
Cardiac output (CO) Plasma volume
End tidal partial pressure of carbon
dioxide (PETCO2)
Glomerular filtration rate (GFR)
Plasma potassium concentration (plasma K+)
Plasma sodium concentration (plasma Na+)Blood pressure (BP)
Plasma renin activity
Plasma aldosterone
Alveolar ventilation (VA) Free water clearance
Adrenocorticotropic hormone (ACTH)Volume of CO2 produced (VCO2)
Anti-diuretic hormone (ADH)
Anti-naturetic protein (ANP)
Blood base excess
Urine sodium-potassium ratio (urine Na+/K+)Volume of oxygen consumed (VO2)
Catecholamines, plasma osmolarity
PH
End tidal fraction of oxygen (FetO2) Urine osmolarity
Plasma lactate levels
Blood NO metabolites
Glutathione peroxidase (GPX)
MDA
Nitrotyrosine
End tidal fraction of oxygen (FetCO2) Plasma advanced oxidation protein
products and superoxide dismutase
Duration of inspiration and expiration Haematocrit (Hct)
Haemoglobin concentration (Hb conc)Hypoxic ventilatory response (HVR)
Respiratory quotient (RQ)
Peripheral oxygen saturations (SpO2)
Arterial oxygen saturations (SaO2)
Arterial oxygen and carbon dioxide
partial pressure (PaO2) (PaCO2)
Arterial oxygen content
Alveolar-arterial PO2 difference
All the variables measured in the 13 accepted studies are listed. These have been subdivided into physiological systems.
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studies where this was reported (Figure 3: Graph of tidal
volume) [12,17,18,21,22]. The largest difference in tidalvolume found in a study was 0.9 L [12]. Two of the seven
studies reporting breathing frequency found it to be
higher in HH [17,18], whilst two others reported lower
Table 2 Study design
Author and year Type of outcome variable Population
PiO2 of exposure (calculated by
PiO2 = (Pb-47) × FiO2 [4]) (mmHg) Duration of exposure
(h:min)
Randomised
(Y, N)
Washout period
between trials (days:h)
NH HH
Basualto-Alarcon 2012
Ventilatory and
cardiovascular + exercise
7 men 3,000 mc 3,000 mc 00:15 builda, 00:10 N 7
Degache 2012 Postural stability 12 men 118 and 102 121 and 103 00:20–25 builda, 00:30b Nil stated <00:24
Hemmingsson 2009 Exhaled NO 6 men, 2 women 103 and 81 99 and 75 00:10 at each altitude Y <00:12
Loeppky 2005 Fluid balance 9 men 81 80 00:05 builda 10:00 Y 7
Loeppky 1997* Ventilatory and cardiovascular 9 men 81 80 00:05 builda 10:00 Y 7
Miyagawa 2010
Ventilatory, cardiovascular
and sweat + exercise
7 men 93 97 00:30 builda only for HH 01:40 Y >6
Naughton 1995 Haematological + exercise
9 subjects with chronic airflow
limitation (CAL) with 6 controls
1,829 and 2,438 mc 117 and 108 00:12 builda included 00:52:00 Y 00:02
Roach 1996 AMS and cardiovascular 9 men 4,564 mc 80 09:00 Y 7
Savourey 2003 Ventilatory and cardiovascular 18 men 4,500 mc 4,500 mc 00:10 builda, 00:30 Y 7
Savourey 2007 Ventilatory and cardiovascular 17 men, 1 woman 4,500 mc 4,500 mc 00:10 builda, 00:30 Y 14
Self 2011 AMS and cardiovascular 17 men and 3 women 7,620 mc 7,620 mc 00:05 N <00:24
Tucker 1983 Mixed 11 men 82 80 00:15 builda included 02:20 N Several weeks
Faiss 2013
Exhaled NO, ventilatory and
cardiovascular + exercise
10 men 99 101 24:00:00 Y 23
This table describes all the features of the accepted studies.
aWhen the subjects entered the chamber, the environmental conditions were that of normal sea level but then were gradually made more hypoxic over the specified amount of time until the target hypoxic dose
was reached.
bThe different altitudes were tested consecutively. So sometimes the exposure was 1 h at 3,000 or 1,700 m.
cWhen PiO2 could not be calculated due to lack of information, the equivalent attitude estimated by the authors was given.
*P values were for three conditions; in recovery no P values unless stated in the discussion.
C
oppelet
al.Extrem
e
Physiology
&
M
edicine
 (2015) 4:2 
Page
5
of
20
Table 3 Oxygenation and ventilation variables
Outcome Author and year Duration of
exposure
(h:min)
Hypobaric hypoxia
result [mean (SD)]
Normobaric
hypoxia result
[mean (SD)]
Difference
(HH − NH) P value
Direction of
difference NH
compared to HH
VE (L/min)
Loeppky 1997 00:00 12.9 13.6 - - -
Savourey 2007 00:10 build, 00:05 10.49 (2.59) 10.14 (1.51) - >0.05 NS
Basualto-Alarcon
2012
00:15 build, 00:05
acclimatisation 10.5 (4.9) 10.3 (1.8) 0.2 - -
Basualto-Alarcon
2012
00:15 build, 00:10
acclimatisation 35.7 (5.9) 39.7 (6.7) -4 <0.05 NH > HH
Savourey 2003 00:10 build, 00:30 - - - <0.02 NH > HH
Savourey 2007 00:10 build, 00:30 10.70 (1.93) 10.78 (1.93) - >0.05 NS
Faiss 2013 01:00 13.6 (1.8) 13.3 (3.3) 0.3 >0.05 NS
Miyagawa 2010a 01:05 69.2 65.6 - >0.05 NS
Miyagawa 2010 01:10 70.5 65.7 - >0.05 NS
Miyagawa 2010 01:20 73.9 70.9 - >0.05 NS
Miyagawa 2010 01:40 75.3 77 - >0.05 NS
Tucker 1983b 02:20 including
00:15 build 2.07 4.82 −2.75 - -
Loeppky 1997 03:00 10.3 14.3 −4.0 <0.01 NH > HH
Loeppky 1997 06:00 10.6 12.7 −2.1 <0.05 NH > HH
Faiss 2013 08:00 11.8 (1.9) 14.9 (3.5) −3.1 <0.1 NH > HH
- 10.7 (1.8) 12.2 (1.6) −1.5 <0.05 NH > HH
- 12.7 (2.3) 14.2 (1.5) −1.5 <0.1 NH > HH
Loeppky 1997 09:00 10.2 12.2 - <0.05 NH > HH
Loeppky 1997 Recovery 12:00:00 9.2 10.1 - >0.05 NS
VT (L)
Savourey 2007 00:10 buildc, 00:05 0.72 (0.25) 0.88 (0.22) - 0.03 NH > HH
Basualto-Alarcon
2012
00:15 buildc, 00:05
acclimatisation 0.81 (0.36) 0.82 (0.21) −0.01 - -
Basualto-Alarcon
2012
00:15 buildc, 00:10
acclimatisation 1.85 (0.56) 1.91 (0.53) −0.06 - NH > HH
Savourey 2003 00:10 buildc, 00:30 - - - <0.001 NH > HH
Savourey 2007 00:10 buildc, 00:30 0.83 (0.37) 0.86 (0.34) - >0.05 NS
Faiss 2013 01:00 0.88 (0.21) 0.89 (0.26) −0.01 >0.05 NS
Tucker 1983b 02:20 including
00:15 buildc 106 152 -46 - NH > HH
Faiss 2013 08:00 0.75 (0.21) 0.94 (0.3) −0.19 <0.05 NH > HH
Faiss 2013 16:00 0.75 (0.23) 0.84 (0.24) −0.9 <0.1 NH > HH
Loeppky 1997 10:00 - - - >0.05 NS
Faiss 2013 24:00:00 0.86 (0.25) 0.95 (0.23) −0.09 <0.05 NH > HH
Bf (cycles/min)
Savourey 2007 00:10 buildc, 00:05 15.73 (4.64) 12.24 (3.80) - 0.03 HH > NH
Basualto-Alarcon
2012
00:15 buildc, 00:05
acclimatisation 13.3 (4.0) 13.4 (4.7) −0.1 - -
Basualto-Alarcon
2012
00:15 buildc, 00:10
acclimatisation 20.4 (5.4) 22.3 (7.4) −1.9 <0.05 NH > HH
Savourey 2003 00:10 buildc, 00:30 - - - <0.001 HH > NH
Savourey 2007 00:10 buildc, 00:30 14.77 (4.17) 13.76 (4.47) - >0.05 NS
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Faiss 2013 01:00 16.8 (3.4) 15.9 (4.2) −0.9 >0.05 NS
Miyagawa 2010 01:05 31 31 - >0.05 NS
Miyagawa 2010 01:10 32 34 - >0.05 NS
Miyagawa 2010 01:20 34 36 - >0.05 NS
Miyagawa 2010 01:40 38 42 - >0.05 NS
Tucker 1983b 02:20 including
00:15 buildc 0.9 3.8 −2.9 - NH > HH
Faiss 2013 08:00 16.8 (2.7) 17.1 (4.4) −0.3 >0.05 NS
Loeppky 1997 10:00 - - - >0.05 NS
Faiss 2013 16:00 16.1 (3) 15.8 (3.7) −0.3 >0.05 NS
Faiss 2013 24:00:00 16.8 (3.8) 16.2 (3.8) 0.6 >0.05 NS
PetO2 (mmHg)
Savourey 2007
00:10 buildc, 00:05 72.5 (6.58) 79.56 (11.94) - 0.08
Borderline NH >
HH
Savourey 2003 00:10 buildc, 00:30 - - - >0.05 NS
Savourey 2007
00:10 buildc, 00:30 73.15 (7.16) 76.09 (11.61) - 0.08
Borderline NH >
HH
Faiss 2013 01:00 66.4 (4.1) 62.3 (2.8) - 4.1 NS
Tucker 1983b 02:20 including
00:15 buildc −36.1 −32.6 −3.5 - -
Faiss 2013 08:00 61.9 (6.0) 61.6 (2.2) 0.3 >0.05 NS
Loeppky 1997 10:00 - - - >0.05 NS
Faiss 2013 16:00 65.0 (5.4) 62.7 (2.6) 2.3 >0.05 NS
Faiss 2013 24:00:00 65.6 (5.5) 65.6 (2.8) 0 >0.05 NS
PetCO2 (mmHg)
Savourey 2007
00:10 build, 00:05 44.09 (6.38) 48.87 (5.53) - 0.05
Borderline NH >
HH
Savourey 2003 00:10 build, 00:30 - - - >0.05 NS
Savourey 2007 00:10 build, 00:30 43.43 (6.02) 46.13 (6.61) - >0.05 NS
Faiss 2013 01:00 33.4 (2.5) 29.4 (2.4) 4 <0.1 HH > NH
Tucker 1983c 02:20 including
00:15 build −2.8 −3.6 0.8 >0.05 NS
Faiss 2013 08:00 33.8 (2.1) 27.5 (1.3) 6.3 <0.01 HH > NH
Loeppky 1997 10:00 - - −1.6 <0.02 NH > HH
Faiss 2013 16:00 33.1 (1.3) 27.9 (0.9) 5.2 <0.01 HH > NH
Faiss 2013 24:00:00 30.8 (1.4) 26.5 (1.5) 4.3 <0.01 HH > NH
VA (alveolar
ventilation L/min)
Loeppky 1997 00:00 9.4 10.1 - - -
Loeppky 1997 03:00 7.2 10.5 −46% <0.05 NH > HH
Loeppky 1997 06:00 7.6 9.1 - <0.05 NH > HH
Loeppky 1997 09:00 7.6 9.2 - <0.05 NH > HH
Loeppky 1997 Recovery 12:00:00 6.7 7.2 - - -
VCO2 ml/min
Loeppky 1997 00:00 295 333 - - -
Miyagawa 2010 01:05 2188 2108 - >0.05 NS
Miyagawa 2010 01:10 2121 2007 - >0.05 NS
Miyagawa 2010 01:20 2078 2060 - >0.05 NS
Coppel et al. Extreme Physiology & Medicine  (2015) 4:2 Page 7 of 20
Table 3 Oxygenation and ventilation variables (Continued)
Miyagawa 2010 01:40 2021 2082 - >0.05 NS
Loeppky 1997 03:00 216 330 - <0.05 NH > HH
Loeppky 1997 06:00 227 296 - <0.05 NH > HH
Loeppky 1997 09:00 235 302 −67 <0.05 NH > HH
Loeppky 1997 Recovery 12:00 241 267 - - -
VO2 consumed
Loeppky 1997 00:00 329 340 - - -
Miyagawa 2010 01:05 1709 1611 - >0.05 NS
Miyagawa 2010 01:10 1783 1637 - >0.05 NS
Miyagawa 2010 01:20 1826 1748 - >0.05 NS
Miyagawa 2010 01:40 1836 1840 - >0.05 NS
Loeppky 1997 03:00 250 361 - <0.05 NH > HH
Loeppky 1997 06:00 262 319 - <0.05 NH > HH
Loeppky 1997 09:00 278 326 - <0.05 NH > HH
Loeppky 1997 12:00 301 291 - - -
FetO2
Savourey 2007 00:10 buildc, 00:05 - - - >0.05 NS
Savourey 2003 00:10 buildc, 00:30 - - - <0.00001 HH > NH
Savourey 2007 00:10 buildc, 00:30 - - - >0.05 NS
FetCO2
Savourey 2007 00:10 build, 00:05 - - - >0.05 NS
Savourey 2003 00:10 build, 00:30 - - - <0.00001 HH > NH
Savourey 2007 00:10 build, 00:30 - - - >0.05 NS
Duration of
inspiration/s
Savourey 2007 00:10 buildc, 00:05 1.94 (0.65) 2.99 (0.98) - 0.01 NH > HH
Savourey 2007 00:10 buildc, 00:30 2.40 (1.25) 3.00 (1.16) - >0.05 NS
Duration of expiration/s
Savourey 2007 00:10 buildc, 00:05 2.09 (0.87) 1.98 (0.84) - >0.05 NS
Savourey 2007 00:10 buildc, 00:30 - - - >0.05 NS
Hypoxic ventilatory
response (HVR) 1%−1
Savourey 2007 00:10 buildc, 00:05 −0.05 0.03 - >0.05 NS
Savourey 2007 00:10 buildc, 00:30 −0.09 −0.07 - >0.05 NS
SpO2 (%)
Savourey 2007 00:10 buildc, 00:05 83.03 (4.49) 87.11 (4.81) −4.08 <0.05 NH > HH
Basualto-Alarcon
2012
00:15 buildc, 00:05
acclimatisation 91.6 (4.2) 89.1 (3.8) 2.5 <0.05 HH > NH
Basualto-Alarcon
2012
00:15 buildc, 00:10
acclimatisation 85.3 (3.8) 86.0 (1.7) −0.7 - -
Savourey 2003 00:10 buildc, 00:30 - - - <0.05 NH > HH
Savourey 2007 00:10 buildc, 00:30 82.49 (4.39) 85.50 (4.84) −2.99 0.04 NH > HH
Faiss 2013 01:00 93 (1) 90 (3) 3 >0.05 NS
Tucker 1983b 02:20 including
00:15 buildc −13.2 −13.5 0.3 >0.05 NS
Faiss 2013 08:00 91 (3) 91 (3) 0 >0.05 NS
Roach 1996 09:00 83% (1%) 83% (0.7%) 0 >0.05 NS
Loeppky 2005 10:00 82% 83% −1% >0.05 NS
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Table 3 Oxygenation and ventilation variables (Continued)
Loeppky 1997 10:00 - - - >0.05 NS
Faiss 2013 16:00 92 (2) 91 (2) 1 >0.05 NS
Faiss 2013 24:00:00 93 (2) 92 (1) 1 >0.05 NS
SaO2 (%)
Self 2011 00:05 - - - 0.005 NH > HH
Savourey 2007 00:10 buildc, 00:05 - - - >0.05 NS
Savourey 2003 00:10 buildc, 00:30 85% (4) 88% (3) −3 <0.05 NH > HH
Savourey 2007
00:10 buildc, 00:30 81.09% (7.76) 85.48% (5.63) −4.39 0.07
Borderline NH >
HH
Miyagawa 2010 01:05 82 83 −1 >0.05 NS
Miyagawa 2010 01:10 81 82 −1 >0.05 NS
Miyagawa 2010 01:20 81 82 −1 >0.05 NS
Miyagawa 2010 01:40 82 81 1 >0.05 NS
Roach 1996 09:00 83% (1%) 83% (0.7%) 0 >0.05 NS
PaO2
Self 2011 00:05 - - - 0.004 HH > NH
Savourey 2007 00:10 buildc, 00:05 - - - >0.05 NS
Savourey 2003
00:10 buildc, 00:30 6.38 (0.60) 6.90 (0.86) −0.52 ≤0.05
Borderline NH>
HH
Savourey 2007 00:10 buildc, 00:30 - - - >0.05 NS
CAL subjects Naughton 1995 00:52 - - −1.1 >0.05 NS
Control subjects Naughton 1995 00:52 - - 0.7 >0.05 NS
PaCO2
Self 2011 00:05 - - - 0.005 NH > HH
Savourey 2007 00:10 build, 00:05 - - - >0.05 NS
Savourey 2003
00:10 build, 00:30 4.65 (0.54) 5.06 (0.46) −0.41 ≤0.05
Borderline NH >
HH
Savourey 2007 00:10 build, 00:30 46.3 (6.5) 52.2 (4.2) −5.9 0.005 NH > HH
CAL subjects Naughton 1995 00:52 - - 0.3 >0.05 NS
Control subjects Naughton 1995 00:52 - - −0.8 >0.05 NS
Tucker 1983b 02:20 including
00:15 build −3.7 −5.6 1.9 - -
Alveolar-arterial PO2
difference
CAL subjects Naughton 1995 00:52 - - 0.7 >0.05 NS
Control subjects Naughton 1995 00:52 - - 0.2 >0.05 NS
Arterial O2 content
Savourey 2007 00:10 buildc, 00:05 - - - >0.05 NS
Savourey 2007 00:10 buildc, 00:30 - - - >0.05 NS
This table lists all the values of the measured variables that relate to oxygenation and ventilation.
NS insignificant, hyphen no values given, CAL Chronic Airflow Limitation.
aExercise started at 01:00.
bDifference from controls.
cWhen the subjects entered the chamber, the environmental conditions were that of normal sea level but then were gradually made more hypoxic over the
specified amount of time until the target hypoxic dose was reached.
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remainder [12,13,15] (Figure 4: Graph of breathing fre-
quency). The only study that reported alveolar ventilation
found that it was higher in NH than HH [13].Oxygenation
The peripheral oxygen saturations measured by pulse
oximetry (SpO2) were significantly lower in HH in two
out of three short studies [17,18]. One study found that
Table 4 Cardiovascular variables
Outcomes Author and year Duration of
exposure (h:min)
Hypobaric hypoxia
result [mean (SD)]
Normobaric hypoxia
result [mean (SD)]
Difference
(HH − NH)
P value Direction of
difference NH
compared to HH
Hypoxic cardiac
response (HCR)
bpm %−1
Savourey 2007 00:10 builda, 00:05 −0.61 −0.63 0.02 >0.05 NS
Savourey 2007 00:10 builda, 00:30 −0.52 −0.79 0.27 >0.05 NS
LF/HF%
Basualto-Alarcon 2012 00:15 builda, 00:10
acclimatisation
1.96 (2.6) 1.28 (0.92) 0.68 <0.05 HH > NH
HR
Self 2011 00:01 104.9 (14.3) 96.6 (14.6) 8.3 <0.05 HH > NH
Self 2011 00:04 - - - >0.05 NS
Basualto-Alarcon 2012 00:15 builda, 00:05
acclimatisation
61 (9) 62 (6) −1 - -
Basualto-Alarcon 2012 00:15 builda, 00:10
acclimatisation
129 (23) 134 (16) −5 <0.05 NH > HH
Savourey 2007 00:10 builda, 00:05 70.32 (9.91) 69.62 (9.95) >0.05 NS
Savourey 2003 00:10 builda, 00:30 - - - <0.05 HH > NH
Savourey 2007 00:10 builda, 00:30 69.50 (12.07) 70.67 (12.07) - >0.05 NS
Faiss 2013 01:00 62 (8) 63 (10) −1 >0.05 NS
Miyagawa 2010 01:05 144 137 - >0.05 NS
Miyagawa 2010 01:10 150 146 - >0.05 NS
Miyagawa 2010 01:40 166 164 - >0.05 NS
Tucker 1983a 02:20 including
00:15 builda
10.4 3.6 6.8 - HH > NH
Faiss 2013 08:00 68 (13) 69 (13) −1 >0.05 NS
Faiss 2013 16:00 61 (10) 66 (7) −5 >0.05 NS
Faiss 2013 24:00 65 (9) 71 (10) −6 >0.05 NS
Stroke volume
Miyagawa 2010 01:05 105 107 −2 >0.05 NS
Miyagawa 2010 01:10 113 126 −13 >0.05 NS
Miyagawa 2010 01:40 116 124 −8 >0.05 NS
Cardiac output
Miyagawa 2010 01:05 15.3 14.7 >0.05 NS
Miyagawa 2010 01:10 17.1 18.2 >0.05 NS
Miyagawa 2010 01:40 19.4 20.1 >0.05 NS
Mean BP
Miyagawa 2010 01:05 112 107 >0.05 NS
Miyagawa 2010 01:10 108 107 >0.05 NS
Miyagawa 2010 01:40 100 99 >0.05 NS
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Table 4 Cardiovascular variables (Continued)
BP systolic (Torr)
Faiss 2013 01:00 124 (9) 129 (13) −5 >0.05 NS
Tucker 1983b 02:20 including
00:15 builda
−1 5 −6 NH > HH
Faiss 2013 08:00 124 (9) 123 (7) 1 >0.05 NS
Faiss 2013 16:00 121 (9) 118 (9) 3 >0.05 NS
Faiss 2013 24:00:00 131 (10) 129 (9) 2 >0.05 NS
This table lists all the values of the measured variables that relate to the cardiovascular system.
NS insignificant.
aWhen the subjects entered the chamber, the environmental conditions were that of normal sea level but then were gradually made more hypoxic over the
specified amount of time until the target hypoxic dose was reached.
bDifference from controls.
Table 5 AMS and neurology variables
Outcome Author andyear
Duration of
exposure (h:min)
Hypobaric hypoxia
result [mean (SD)]
Normobaric hypoxia
result [mean (SD)]
Difference
(HH − NH) P value
Direction of difference
NH compared to HH
Length of centre
of pressure trajectory
in Y axis
Eyes open 1,700 m Degache 2012 00:30 114.2 (38.8) 129.5 (53.3) -15.3 - NH > HH
Eyes closed 1,700 m Degache 2012 00:30 127.2 (54.9) 87.7 (44.8) 39.5 - HH > NH
Dual task 1,700 m Degache 2012 00:30 128.7 (87.1) 79.9 (30.3) 48.8 - HH > NH
Romberg’s index
1,700 m Degache 2012 00:30 1.35 (0.19) 1.42 (0.34) -0.07 - -
Eyes open 3,000 m Degache 2012 00:30 123.1 (22.6) 127.2 (41.5) -4.1 - -
Eyes closed 3,000 m Degache 2012 00:30 104.7 (27.0) 89.1 (39.9) 15.6 - HH > NH
Dual task 3,000 m Degache 2012 00:30 91.9 (22.4) 82.4 (30.4) 9.5 - HH > NH
Romberg’s index
3,000 m Degache 2012 00:30 1.33 (0.22) 1.39 (0.29) -0.06 - -
Variance of speed
of CoP
Eyes open 1,700 m Degache 2012 00:30 111.0 (56.2) 151.4 (30.2) -40.4 - NH > NH
Eyes closed 1,700 m Degache 2012 00:30 111.0 (58.8) 149.9 (31.5) -38.9 - NH > HH
Dual task 1,700 m Degache 2012 00:30 112.1 (57.7) 151.1 (31.7) -39 - NH > HH
Romberg’s index
1,700 m Degache 2012 00:30 0.98 (0.09) 0.99 (0.03) -0.01 - -
Eyes open 3,000 m Degache 2012 00:30 150.5 (42.3) 160.8 (14.0) -10.3 - NH > HH
Eyes closed 3,000 m Degache 2012 00:30 142.9 (40.8) 158.6 (13.7) -15.7 - NH > HH
Dual task 3,000 m Degache 2012 00:30 143.4 (39.2) 160.1 (15.0) -16.7 - NH > HH
Romberg’s index
3,000 m Degache 2012 00:30 0.95 (0.11) 0.99 (0.02) -0.04 - -
Lake Louise AMS
scores
Self 2011 00:01 - - 2.36 >0.05 NS
Self 2011 00:04 - - -4.89 >0.05 NS
Roach 1996 09:00 - - - <0.01 HH > NH
Loeppky 2005* 10:00 - - - <0.001 HH > NH
This table lists all the values of the measured variables that relate to AMS and neurology.
NS insignificant.
*P value calculated including hypobaric normoxia.
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Table 6 Additional physiological variables
Outcome Author and year Duration of
exposure (h:min)
Hypobaric
hypoxia result
[mean (SD)]
Normobaric
hypoxia result
[mean (SD)]
Difference
(HH − NH)
P value Direction of
difference NH
compared to HH
Exhaled NO (PE NO)
Hemmingsson 2009
00:10 at each
ascending altitude - -
33% mean
reduction
(at 5,000 m) 0.002 NH > HH
Faiss 2013 01:00 9.5 (5.0) 14.9 (9.2) −5.4 <0.01 NH > HH
Faiss 2013 08:00 8.8 (5.3) 14.1 (7.4) −5.3 <0.01 NH > HH
Faiss 2013 16:00 7.9 (4.5) 14.7 (8.6) −6.8 <0.01 NH > HH
Faiss 2013 24:00:00 8.9 (5.4) 15.7 (8.7) −5.8 <0.01 NH > HH
RQ
Self 2011 00:05 2.37 (0.53) 1.41 (0.15) 0.96 0.005 HH > NH
Forced vascular conductance
Miyagawa 2010 01:00-01:40 - - - >0.05 NS
Sweat rate
Miyagawa 2010 01:00-01:40 - - - >0.05 NS
Oesophageal temperature
thresholds for increasing
forearm skin vascular
conductance
Miyagawa 2010 01:00-01:40 - - - >0.05 NS
Oesophageal temperature
thresholds for increasing
sweat rate
Miyagawa 2010 01:00-01:40 - - - >0.05 NS
Oesophageal temperature
Miyagawa 2010 01:05 36.63 36.61 0.02 >0.05 NS
Miyagawa 2010 01:10 37.12 37.11 0.01 >0.05 NS
Miyagawa 2010 01:40 37.95 37.96 −0.01 >0.05 NS
Skin temperature
Miyagawa 2010 01:05 33.37 33.47 −0.1 >0.05 NS
Miyagawa 2010 01:10 33.35 33.43 −0.08 >0.05 NS
Miyagawa 2010 01:40 34.44 34.59 −0.15 >0.05 NS
Urine vol (ml)
Loeppky 2005a 10:00 - - - 0.005 HH > NH
Tucker 1983b 02:20 including
00:15 buildd −1.6 0.1 −1.7 - NH > HH
Plasma volume
Miyagawa 2010 01:00-01:40 - - - >0.05 NS
Loeppky 2005 10:00 - - −6% 0.002** HH > NH
GFR
Loeppky 2005 10:00 - - - >0.05 NS
Plasma K+
Loeppky 2005 10:00 - - - 0.003 NH > HH
Plasma Na+
Loeppky 2005 10:00 - - - 0.006 NH > HH
Plasma renin activity (PRA)
Loeppky 2005a 10:00 - - - <0.05 HH > NH
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Table 6 Additional physiological variables (Continued)
Plasma aldosterone
Loeppky 2005a 10:00 - - - <0.001 NH > HH
Free water clearance (CH2O)
Loeppky 2005a 10:00 - - - <0.05 HH > NH
ACTH
Loeppky 2005a 10:00 - - - 0.18 NS
ADH
Loeppky 2005 10:00 - - - >0.05 NS
ANP
Loeppky 2005* 10:00 - - - 0.97 NS
Blood base excess
Loeppky 2005 10:00 - - - >0.05 NS
Urine Na+/K+
Loeppky 2005 10:00 - - - 0.7 NS
Catecholamines
Miyagawa 2010 01:00-01:40 - - - >0.05 NS
Loeppky 2005 10:00 - - - 0.43 NS
Haematocrit
Miyagawa 2010 01:00-01:40 - - - >0.05 NS
Tucker 1983b 02:20 including
00:15 buildd 0.7 0.7 0 NS
Haemoglobin concentration
Savourey 2007 00:10 buildd, 00:05 - - - >0.05 NS
Savourey 2007 00:10 buildd, 00:30 - - - >0.05 NS
Miyagawa 2010 01:00-01:40 - - - >0.05 NS
Plasma osmolarity
(mOsm)
Miyagawa 2010 01:00-01:40 - - - >0.05 NS
Tucker 1983b 02:20 including
00:15 buildd −0.4 −1 0.6 - HH > NH
pH
Savourey 2003 00:10 buildd, 00:30 7.46 (SEM 0.03) 7.44 (SEM 0.02) 0.02 ≤0.05 Borderline HH >NH
Savourey 2007 00:10 buildd, 00:30 7.45 (0.04) 7.44 (0.04) 0.01 0.02 HH > NH
CAL subjects
Naughton 1995 00:52 - - −0.02 >0.05 NS
Control subjects
Naughton 1995 00:52 - - 0.01 >0.05 NS
Tucker 1983d 02:20 including
00:15 buildd 0.047 0.015 0.032 - HH > NH
Faiss 2013 24:00:00 - - - <0.01 NH > HH
Urine osmolarity (mOsm)
Tucker 1983c 02:20 including
00:15 buildb 15 0.1 14.9 - HH > NH
Lactate mmol/kgH2O
Miyagawa 2010 01:00-01:40 - - - >0.05 NS
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Table 6 Additional physiological variables (Continued)
Blood NO metabolites
Faiss 2013 01:00 31.6 (19.6) 27.7 (7.3) 3.9 <0.01 HH > NH
Faiss 2013 08:00 28.1 (18.9) 32.7 (9.7) −4.6 <0.01 NH > HH
Faiss 2013 16:00 24.2 (16.3) 30.2 (7.1) −6 <0.01 NH > HH
Faiss 2013 24:00 22.85 (16.2) 28.9 (6.9) −6.05 <0.01 NH > HH
GPX (% baseline)
Faiss 2013 01:00 114 (26) 111 (30) 3 >0.05 NS
Faiss 2013 08:00 85 (27) 123 (23) −37 >0.05 NS
Faiss 2013 16:00 105 (43) 107 (21) −2 >0.05 NS
Faiss 2013 24:00 103 (43) 107 (21) −4 >0.05 NS
MDA (% baseline)
Faiss 2013 01:00 117 (40) 92 (36) 25 >0.05 NS
Faiss 2013 08:00 103 (62) 111 (35) −8 >0.05 NS
Faiss 2013 16:00 111 (56) 116 (55) −5 >0.05 NS
Faiss 2013 24:00 108 (52) 97 (51) 11 >0.05 NS
Nitrotyrosine (% baseline)
Faiss 2013 01:00 86 (16) 105 (26) −19 >0.05 NS
Faiss 2013 08:00 77 (35) 75 (37) 2 >0.05 NS
Faiss 2013 16:00 91 (20) 98 (16) −7 >0.05 NS
Faiss 2013 24:00 75 (40) 87 (25) −12 >0.05 NS
Plasma advanced oxidation
protein products
Faiss 2013 01:00 120% 13% 107% - NH > HH
Faiss 2013 24:00 260% 88% 172% - NH > HH
Superoxide dismutase Faiss 2013 24:00 - - 37% - NH > HH
This table lists all the values of all other the measured physiological variables.
NS insignificant, SEM Standard Error of the Mean.
aMeasured 2 h after exposure.
bDifference from controls.
cSubjects were gradually exposed increasing levels of hypoxia over the stated time until the target hypoxic dose was reached.
dWhen the subjects entered the chamber, the environmental conditions were that of normal sea level but then were gradually made more hypoxic over the
specified amount of time until the target hypoxic dose was reached.
*P value calculated including hypobaric normoxia.
**P value calculated including hypobaric normoxia and after 3 h.
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no differences were found in all five of the long studies
[12-14,16,22]. The arterial blood saturations (SaO2) were
lower in HH in all three short studies [6,17,18] but not
in the two longer studies [15,16]. Arterial partial pres-
sures of oxygen (PaO2) was lower in NH in one study
[6], higher in NH in one study [17], and no different in
two studies [18,20] (Table 3: Oxygenation and ventila-
tion). Only the two studies by Savourey et al. [17,18]
measured the end tidal fractions of O2 and these report
discordant results. In 2003, Savourey et al. [17] found
the end tidal fractions of O2 to be higher (P < 0.00001)
in HH than NH; however, in their 2007 [18] study follow-
ing the same protocols, no difference was demonstrated
(P > 0.05).Carbon dioxide (CO2) clearance
In three out of five studies, there was no difference in
the end tidal partial pressure of CO2 (PETCO2) between
HH and NH [17,18,22]; however, one study [12] found it
to be higher in HH and one found it to be lower in HH
[13]. In four out of five studies, the PaCO2 levels were
lower [11,17,13] or the same [20] in HH compared to
NH. For example, one study found the difference in
PaCO2 to be as large as 5.9 hPa lower in HH [18]. Two
studies measured the end tidal fractions of CO2 [17,18].
In 2003, Savourey et al. [17] found the end tidal fractions
of CO2 to be higher (P < 0.00001) in HH than NH,
whereas in the same group's 2007 study [18] (following
the same protocols), no difference was demonstrated
(P > 0.05).
Figure 2 Graph of minute ventilation. Graph to show the difference in minute ventilation between the two environments over time. Each data
point represents data obtained from a study and the number refers to the time point. If the data point is in the green area, the minute ventilation was
found to be higher in HH but if in the blue area, the minute ventilation was found to be lower in HH.
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Seven studies were identified that reported physiological
variables relating to the cardiovascular system. Three of
these were long studies [12,15,22] and four were short
studies [6,17,18,21] (Table 4: Cardiovascular variables).
All seven studies measured heart rate (HR). Three found
HR to be higher in HH [6,17,22], one found it to be lower
[21], and the others found no differences [12,15,18]Figure 3 Graph of tidal volume. Graph to show the difference in tidal vo
represents data obtained from a study and the number refers to the time p
to be higher in HH but if in the blue area, the tidal volume was found to b(Figure 5: Graph of heart rates). Three studies measured
blood pressure. Two found no difference in blood pressure
between environments [12,15]; however, one other found
it to be lower in HH than in NH [22]. Sympathetic drive,
measured by a specific electrocardiogram (ECG) recorder
of low- and high-frequency components of heart rate, was
only investigated in one study [21] and was found to be
higher in HH than in NH.lume between the two environments over time. Each data point
oint. If the data point is in the green area, the tidal volume was found
e lower in HH.
Figure 4 Graph of breathing frequency. Graph to show the difference in breathing frequency between the two environments over time. Each
data point represents data obtained from a study and the number refers to the time point. If the data point is in the green area, the breathing
frequency was found to be higher in HH but if in the blue area, the breathing frequency was found to be lower in HH.
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Four studies were found relating to acute mountain sick-
ness (AMS) and neurological symptoms and signs, two
of which were long studies [14,16] and two of which
were short studies [6,23] (Table 5: AMS and neurology).
Two out of three studies [14,16] that measured AMS
scores found that AMS was significantly worse in HH
than in NH. Only one study [23] measured postural sta-
bility, which was significantly reduced in HH comparedFigure 5 Graph of heart rates. Graph to show the difference in heart rate
data obtained from a study and the number refers to the time point. If the da
HH but if in the blue area, the heart rate was found to be lower in HH.to NH. Subjects deviated from the midline more in HH
than NH, and the speed with which movements oc-
curred to correct their posture was slower.
Additional physiological variables
Six studies [6,12,14,15,19,22] researched a variety of other
physiological variables (Table 6: Additional physiological
variables). In three out of five of these studies [17,18,22],
the plasma pH was higher in HH than NH; however, one ofbetween the two environments over time. Each data point represents
ta point is in the green area, the heart rate was found to be higher in
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(Figure 6: Graph of pH). The greatest difference in pH
found in a study was 0.032 [22]. Urine osmolarity was mea-
sured in only one study and was significantly higher in HH
[22]. Additionally, the same study was the only one to
measure the volume of urine produced and found it to be
lower during HH exposure [22]. One study also measured
K+, Na+ and aldosterone concentrations in plasma and
found they were higher in NH [14]. In recovery post-
hypoxic exposure, authors in [14] found that the urine vol-
ume, plasma renin activity and free water clearance were
higher whilst aldosterone was lower after HH than NH.
This was the only study to measure these variables.
Only two studies [12,19] measured exhaled NO levels
and both found that they were lower in HH than in
NH. The greatest difference in exhaled NO found in
these papers was 6.8 mmHg [12]. Additionally, only
one study measured systemic NO and the authors
found it was lower in HH [12]. The same study was the
only study to measure plasma-advanced oxidation pro-
tein products and superoxide dismutase. These were
higher in HH [12]. Only one study [6] measured the re-
spiratory quotient (RQ) and found it was higher in HH
than NH.
Review: discussion
Summary of physiological findings
We believe this is the first systematic review com-
paring the effect of NH and HH on human physiology.Figure 6 Graph of pHs. Graph to show the difference in pH between the t
from a study and the number refers to the time point. If the data point is in t
area, the pH was found to be lower in HH.Significant differences were demonstrated in variables
relating to ventilation, NO, fluid retention, and in fac-
tors relating to AMS. For other variables, there was no
consistent pattern across the reviewed studies.Oxygenation and ventilation parameters
The majority of studies included data relating to oxygenation
and ventilation. Oxygen saturations measured from pulse
oximetry (SpO2) and arterial blood gases correlated with each
other. During short-term exposure, oxygen saturations were
lower in HH [6,17]. This was not the case for long-term
exposure, perhaps as the initial process of acclimatisation to
hypoxia had occurred [18,20]. PaO2 did not differ at any stage.
A decreased minute ventilation and alveolar ventila-
tion was seen in HH. This finding is in accord with the
smaller tidal volumes demonstrated in HH; however,
breathing frequencies varied [12,13,17,18,21,22]. Despite
the lower SpO2 in HH initially, oxygen saturations were
maintained at the same level in both environments over
longer time periods. Interestingly, despite the reduction
in ventilation, PETCO2 levels did not change significantly
[12,13,17,18,22].
Notably, Savourey et al. found different results in end
tidal fractions of both O2 and CO2 between their two
studies in 2003 [17] and 2007 [18]. This not only makes
interpretation of their results very challenging but also
highlights issues concerning reliability of studies (as
discussed in Study quality section).wo environments over time. Each data point represents data obtained
he green area, the pH was found to be higher in HH but if in the blue
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The majority of these variables were similar for HH and
NH. Heart rate and blood pressure results were incon-
sistent, although some data suggests that heart rate may
be raised initially in HH [6,12,15,17,18,21,22].
AMS and neurology variables
Mountain sickness is an area of research that has
attracted much interest and consequently the multiple
variables that combine to make the Lake Louise AMS
scoring system are commonly collected in these studies.
In two of four studies, AMS severity was found to in-
crease in HH compared with NH [14,16]. Furthermore,
in the one study that found no differences between envi-
ronments [6], participants only had a 5-min exposure
time, as opposed to 9- and 10-h exposures in other stud-
ies. Additionally, postural stability was significantly
worse in HH [23]. The authors suggest that visual con-
trast sensitivity is lower in HH than in NH and that this
may contribute to the postural stability [23].
Other homeostatic variables
Plasma pH appears to be higher in HH than NH
[17,18,22]. The study [20] that did not find significant
differences in pH between the two conditions was con-
ducted at 1,829 and 2,438 m whereas the elevated pH
values were from 4,500 m, suggesting that the differ-
ences between the two conditions may be more pro-
nounced at higher altitudes. Elevated pH in HH is
surprising in the context of the finding that ventilation is
reduced under these conditions.
Exhaled and systemic NO levels were lower in HH
[12,19]. Faiss et al. [12] found increased oxidative stress
in HH and attributed the systemic differences in NO
bioavailability to this.
Many other physiological variables were measured;
however, most of these were reported in only a single
study. Thus, it is difficult to make conclusions without
verification from other studies, and we have not consid-
ered these further.
Study quality
The search results reveal several issues relating to study
design. Very few studies state the reliability of their mea-
surements or performed a sample size calculation. It is
therefore difficult to evaluate if they are adequately pow-
ered to identify a real difference between conditions,
should such a difference exist. Given that differences in
physiological responses between NH and HH conditions
are likely quite small, large sample sizes would likely be
required to avoid type II (false negative) errors. Add-
itionally, by performing statistical analysis on a large
number of variables over many time points, the risk of
type I (false positive) errors increases.Failure to account for the PH2O leads to an overesti-
mate of the hypoxic dose in NH, such that incorrect par-
tial pressure of inspired oxygen (PiO2) may be attained
[11]. In one study [6], a NH exposure equivalent to
7,620 m was described; however, the conditions were in
fact closer to 7,010 m once pH2O was accounted for
[11]. We have emphasised these differences by calculat-
ing, where possible, the PiO2 in the different hypoxic
conditions (Table 2: Study design). We found the differ-
ences in PiO2 to be as much as 4 mmHg. The level of
CO2 in the test environment was a potential source of
error. Basualto-Alarcon et al. [21] highlight this issue in
stating that different gas inflow rates into each hypoxic
system allow different levels of CO2 accumulation. Add-
itionally, they state that their NH environment may have
been more hypercapnic because it had half the total vol-
ume of the hypobaric chamber. These control group
contrast issues will either enhance or diminish the effect
size and therefore the difference between HH and NH.
This may be of particular relevance to ventilator
variables.
Mechanisms for results
Many hypothetical mechanisms have been proposed for
the effect of low barometric pressure on physiology. These
include intravascular bubble formation, increased alveolar
deadspace, altered fluid permeability, changes in chemo-
sensitivity, and a mismatch in ventilation and perfusion
[13,16,17]. Although pressure may be the principle con-
founder between the two scenarios, we must also reflect
that other factors may differ between HH and NH, thus
impacting participant's physiology. For example, the
laboratory-based components of the studies reviewed were
performed between 22°C and 25°C, a temperature likely to
be far warmer that experiences at 4,000 m in a field la-
boratory. Such differences in ambient temperature may
alter physiological mechanisms such as the degree of per-
ipheral vasoconstriction, NO metabolism or the produc-
tion of reactive oxidative species [24].
As highlighted, the duration of the hypoxic exposure
impacts on the results obtained. Different physiological
systems will have different response rates for adaptation
to hypoxia [25]. For some physiological parameters, the
short study durations may not be long enough for dif-
ferences between NH and HH to be elicited. Studies
reporting repeated measures over time provide a win-
dow on this phenomenon. For example, in the 1997
study by Loeppky et al. [13], where no differences in
minute ventilation were reported after 30 or 60 min of
hypoxic exposure, significant differences were evident
after 3 h of exposure. Additionally, Savourey et al.
[17,18] initially found lower PETO2 and PETCO2 in HH
than NH but then no difference in prolonged exposure.
This may be because during HH exposure, the ambient
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the body's and therefore nitrogen (N2) initially diffuses
from the tissues to the alveoli [5]. Until this equilibrium
is achieved, the arterial oxygen content, PAO2, and the
arterial carbon dioxide content, PACO2, are lowered as
a result of the relatively higher PAN2 in HH than NH.
Loeppky et al. [13] also suggests that an initial increase
in CO2 produced in HH compared to NH might be due
to microbubble formation similar to the nitrogen bends
in divers. This emphasises the importance of study
duration on physiological response and the problems
inherent in comparing studies of different hypoxia ex-
posure times.
If there are indeed differences between HH and NH,
at what equivalent altitude do they become apparent?
Most of the studies have been carried out at 4,500 m (or
equivalent), but Naughton et al.'s study [20] performed
at 1,829 and 2,438 m was unable to find any significant
differences between HH and NH. These altitudes corres-
pond to PO2 values of 118 mmHg (15.7 kPa) and
108 mmHg (14.4 kPa) [25] respectively, and it is possible
that these altitudes were not high enough to elicit differ-
ences in the measured variables. Significant differences
between the effects of NH and HH may impact the in-
terpretation and application of results from studies at
high altitude where the change in pressure may be a
confounding influence in the evaluation of physiological
responses to high altitude.
Strengths and limitations of this study
Although this is the first systematic review to summarise
crossover studies comparing physiological responses to
hypobaric and normobaric hypoxia, other publications
have come to similar conclusions on the topic. Millet
et al. [10] stress the importance of disentangling hypoxia
and hypobaria and Fulco et al. [26] highlight the need
for further investigations into NH versus HH, for par-
ticular application to pre-acclimatisation strategies.
The strengths of this systematic review include the clear
research question, comprehensive search strategy and con-
sistent methods used for identifying eligible manuscripts
and extracting data. Limitations of this review include the
focus on crossover studies but are predominantly related
to the quantity and quality of the underlying literature.
There are few studies that compare HH and NH and the
number of participants in each study is small. Whilst sev-
eral of these studies report interesting differences between
HH and NH, there is marked inconsistency in the reported
results. This may be due to a number of other factors
including heterogeneity of study design, duration and mag-
nitude of hypoxic dose and outcome reporting. Further-
more, the reporting of multiple phenotypes in each study
without correction for repeat testing may be associated
with an increased likelihood of type 1 errors. Conversely,the small sample sizes may be associated with an increased
likelihood of type 2 errors.
As mentioned, the studies were heterogeneous by de-
sign. For example, they differed in regard to the subjects'
prior exposure to altitude. In two of the studies reviewed
[16,22], the subjects lived between 1,500 and 1,600 m
and so may have been partially acclimatised to high alti-
tude. It is not clear whether the same effects would be
seen in partially and not acclimatised subjects.
Finally, the self-reported nature of AMS scores could be
associated with inconsistent responses from participants.
In the study by Self et al. [6], there was a disparity between
post-hypoxia interview responses and the responses dur-
ing hypoxic exposure. There is no gold standard method
for these types of studies and so there is much variability
due to the methodology employed.Conclusions
We present an overview of the current available litera-
ture regarding crossover studies relating to the different
effects of HH and NH on human physiology. This sys-
tematic review is the first to compare the effects of a
NH and HH environment on human physiology. Several
studies reported a number of variables (e.g. minute ven-
tilation and NO levels) that were different between the
two conditions, lending support to the notion that true
physiological difference are indeed present. However, the
presence of confounding factors such as time spent in
hypoxia, temperature, and humidity, and the limited
statistical power due to small sample sizes, limit the con-
clusions that can be drawn from these findings.
Standardisation of study methods and reporting may
aid interpretation of future studies and thereby improve
the quality of data in this area. This is important to im-
prove the quality of data that is used both for improving
understanding of hypoxia tolerance, both at altitude and
in the clinical setting.Abbreviations
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